Dihydralazine - Misplaced Pages

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 23:39, 23 October 2011 (Updating {{drugbox}} (changes to verified and watched fields - updated 'ChEBI_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 23:39, 23 October 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (changes to verified and watched fields - updated 'ChEBI_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or bugs))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Dihydralazine" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Pharmaceutical compound

Dihydralazine
Clinical data

AHFS/Drugs.com	International Drug Names
ATC code	C02DB01 (WHO)
Identifiers
IUPAC name 4-hydrazinyl-1-hydrazinylidene-1,2-dihydrophthalazine
CAS Number	484-23-1
PubChem CID	10230
ChemSpider	9813
UNII	PCU411F5L6
KEGG	D07170
ChEMBL	ChEMBL35505
CompTox Dashboard (EPA)	DTXSID0022935
ECHA InfoCard	100.006.914
Chemical and physical data
Formula	C₈H₁₀N₆
Molar mass	190.205 g·mol
3D model (JSmol)	Interactive image
SMILES n2nc(c1ccccc1c2NN)NN
InChI InChI=1S/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14) Key:VQKLRVZQQYVIJW-UHFFFAOYSA-N
(what is this?) (verify)

Dihydralazine is an antihypertensive of the hydrazine chemical class.

References

v t e Nonsympatholytic vasodilatory antihypertensives (C02)
Nitrovasodilator (arterioles and venules)	Nitroprusside #
Hydrazinophthalazines (arterioles)	Hydralazine # Dihydralazine Endralazine Cadralazine Pildralazine
Potassium channel openers (arterioles)	Minoxidil Diazoxide
Calcium channel blockers (arterioles)	see list
WHO-EM Withdrawn from market Clinical trials: Phase III Never to phase III

v t e Hydrazines
4-PTSC Acylhydrazine ADH Adjudin Agaritine Benmoxin Cadralazine Carbazide Carbidopa Carbohydrazide Daminozide Dihydralazine DNPH Endralazine Gyromitrin HBT Hydralazine Hydrazide Hydrazine Hydrazone Iproclozide Iproniazid Isocarboxazid Isoniazid Mebanazine Metfendrazine MMH Nialamide Octamoxin PEH Phenelzine Pheniprazine Phenoxypropazine Phenylhydrazine Pildralazine Pimagedine Pivalylbenzhydrazine Procarbazine Safrazine Semicarbazide Semicarbazone SDMH Tetrafluorohydrazine UDMH

Hydrazines

This antihypertensive-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:

See also

References